FluoGuide A/S (STO:FLUO)
Sweden · Delayed Price · Currency is SEK 32.50
+0.40 (1.25%)
Jul 24, 2026, 4:13 PM CET
FluoGuide Revenue
In the year 2025, FluoGuide had annual revenue of 220.00K DKK, down -42.86%. FluoGuide had revenue of 54.00K in the quarter ending December 31, 2025.
Revenue
220.00K DKK
Revenue Growth
-42.86%
P/S Ratio
1,501.96
Revenue / Employee
32.84K DKK
Employees
7
Market Cap
524.81M SEK
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 220.00K | -165.00K | -42.86% |
| Dec 31, 2024 | 385.00K | -38.00K | -8.98% |
| Dec 31, 2023 | 423.00K | -6.09M | -93.50% |
| Dec 31, 2022 | 6.51M | -3.10M | -32.27% |
| Dec 31, 2021 | 9.61M | 6.40M | 198.73% |
| Dec 31, 2020 | 3.22M | 3.12M | 3,118.00% |
| Dec 31, 2019 | 100.00K | - | - |
| Dec 31, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 317.21M |
| Sprint Bioscience AB | 153.28M |
| Oncopeptides AB | 83.24M |
| Intervacc AB | 18.89M |
| Corline Biomedical AB | 10.67M |
| Medivir AB | 9.01M |
| Xspray Pharma AB | 2.47M |
| Infant Bacterial Therapeutics AB | -1.00K |
FluoGuide News
- 2 months ago - FluoGuide Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - FluoGuide Quarterly report: Q1 2026 - Filings
- 5 months ago - FluoGuide Earnings Call Transcript: Q4 2025 - Transcripts
- 5 months ago - FluoGuide Annual report: Q4 2025 - Filings
- 5 months ago - FluoGuide Quarterly report: Q4 2025 - Filings
- 7 months ago - FluoGuide Slides: SEB Nordic Seminar presentation - Filings
- 8 months ago - FluoGuide Quarterly report: Q3 2025 - Filings
- 10 months ago - FluoGuide Transcript: Investing in Life Science 2025 - Transcripts